TVRD

Tvardi Therapeutics, Inc. Common Stock
TVRD

Overview Fund Activity

182 hedge funds and large institutions have $387M invested in Tvardi Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 71 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+2
Holders Change %
+1.11%
% of All Funds
2.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
71
Closed
23
Calls
$4.35M
Puts
$1.35M
Net Calls
+$3M
Net Calls Change
+$306K

Top Buyers

1
FCM
Farallon Capital Management
California
+$6.07M
2
PA
Pinnacle Associates
New York
+$4.35M
3
KCM
Kingdon Capital Management
New York
+$3.64M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.17M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.57M

Top Sellers

1
SCM
Soleus Capital Management
Connecticut
-$3.26M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.74M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.45M
4
C
Chescapmanager
Maryland
-$1.57M
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
EWA
201
EverSource Wealth Advisors
Alabama
– -$1K -2 Closed
MPWT
202
MassMutual Private Wealth & Trust
Connecticut
– -$1K -1 Closed
CA
203
CoreCap Advisors
Michigan
– -$1K – –
5 6 7 8
9